Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer’s Disease Pathogenesis-Reference-Cited by-同舟云学术

Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer’s Disease Pathogenesis

Published:2015-05-30 Issue:2 Volume:46 Page:313-327
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Ellis Ben¹,Hye Abdul²,Snowden Stuart G.²

Affiliation:

1. Kings College London, School of Medicine, London, UK

2. Institute of Psychiatry, Department of Old Age Psychiatry, Kings College London, London, UK

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference107 articles.

1. Epidemiology of Alzheimer disease;Reitz;Nat Rev Neurol,2011

2. Forecasting the global burden of Alzheimer’s disease;Brookmeyer;Alzheimers Dement,2007

3. Current concepts in Alzheimer’s disease: A multidisciplinary review;Minati;Am J Alzheimers Dis Other Demen,2009

4. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory;Turner;Prog Neurobiol,2003

5. Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer’s disease;El-Agnaf;Biochem Biophys Res Commun,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Metabolite Biomarkers of Multiple Sclerosis from Multiple Biofluids;ACS Chemical Neuroscience;2024-02-29

2. Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease;Scientific Reports;2024-02-16

3. Sphingolipid metabolism in brain insulin resistance and neurological diseases;Frontiers in Endocrinology;2023-10-06

4. Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline;Journal of Alzheimer's Disease Reports;2023-05-03

5. Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline;J ALZHEIMERS DIS REP;2023